Heparin-induced thrombocytopenia and thrombosis.
暂无分享,去创建一个
[1] W. Mäurer,et al. Therapie des Heparin-induzierten Thrombose-Thrombozytopenie-Syndroms mit Immunglobulinen , 2008, Deutsche medizinische Wochenschrift.
[2] B. Chong. Heparin‐induced thrombocytopenia , 2003, British journal of haematology.
[3] M. R. Jackson,et al. Diagnosis of heparin-induced thrombocytopenia in the vascular surgery patient. , 1997, Surgery.
[4] V. Hach-Wunderle,et al. Heparin-related thrombosis despite normal platelet counts in vascular surgery. , 1997, American journal of surgery.
[5] J. Kelton,et al. A 14-year study of heparin-induced thrombocytopenia. , 1996, The American journal of medicine.
[6] Maier Rv,et al. Endothelial changes after shock and injury. , 1996 .
[7] D. Silver,et al. Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome. , 1996, Journal of vascular surgery.
[8] A. Greinacher,et al. Platelets of patients with peripheral arterial disease are hypersensitive to heparin. , 1996, Thrombosis research.
[9] J. Amiral,et al. Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopenia , 1996, British journal of haematology.
[10] A. Jawad,et al. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. , 1995, American journal of clinical pathology.
[11] J. Kelton,et al. Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination. , 1995, American journal of clinical pathology.
[12] J. M. Osborne,et al. On the Role of Platelet FcγRIIa Phenotype in Heparin-Induced Thrombocytopenia , 1995, Thrombosis and Haemostasis.
[13] V. Roongta,et al. Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding. , 1995, The Biochemical journal.
[14] F. Schiele,et al. Use of recombinant hirudin as antithrombotic treatment in patients with heparin‐induced thrombocytopenia , 1995, American journal of hematology.
[15] P. Leder,et al. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.
[16] G. Müller‐Berghaus,et al. Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in man. , 1995, The Journal of thoracic and cardiovascular surgery.
[17] J. Hirsh,et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. , 1995, The New England journal of medicine.
[18] J. Fontcuberta,et al. Heparin-induced thrombocytopenia and heart operation: management with tedelparin. , 1995, The Annals of thoracic surgery.
[19] D. Silver,et al. Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies? , 1995, Journal of vascular surgery.
[20] J. Kelton,et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. , 1994, Blood.
[21] G. Shorten,et al. Management of cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia using prostaglandin E1 and aspirin. , 1994, Journal of cardiothoracic and vascular anesthesia.
[22] A. Greinacher,et al. Platelet response to vascular surgery--a preliminary study on the effect of aspirin and heparin. , 1994, Thrombosis research.
[23] G. Laub,et al. Heparinless cardiopulmonary bypass with ancrod. , 1994, The Annals of thoracic surgery.
[24] J. Kelton,et al. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. , 1994, Blood.
[25] C. Feindel,et al. Successful treatment of massive pulmonary embolism after coronary artery bypass grafting due to heparin-induced thrombocytopenia. , 1994, The Annals of thoracic surgery.
[26] E. Frenkel,et al. Thrombocytopenia. Issues in diagnosis and therapy. , 1994, The Medical clinics of North America.
[27] A. Greinacher,et al. Heparin-Associated Thrombocytopenia: The Effects of Various Intravenous lgG Preparations on Antibody Mediated Platelet Activation - A Possible New Indication for High Dose i.v. IgG , 1994, Thrombosis and Haemostasis.
[28] A. Greinacher,et al. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. , 1994, Thrombosis and haemostasis.
[29] D. Keeling,et al. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin‐induced thrombocytopenia , 1994, British journal of haematology.
[30] H. Magnani. Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172) , 1993, Thrombosis and Haemostasis.
[31] M. J. Kikta,et al. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome? , 1993, Surgery.
[32] J. Maraganore. Thrombin, Thrombin Inhibitors, and the Arterial Thrombotic Process , 1993, Thrombosis and Haemostasis.
[33] D. M. Rothkopf,et al. The Effect of Ibuprofen on Microvascular Thrombosis in an Experimental Rabbit Model , 1993, Annals of plastic surgery.
[34] B. P. Schmitt,et al. Heparin-associated thrombocytopenia: a critical review and pooled analysis. , 1993, The American journal of the medical sciences.
[35] B. Chong,et al. The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia , 1993, Thrombosis and Haemostasis.
[36] J. Brandt,et al. Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia. , 1993, American journal of clinical pathology.
[37] B. Chong,et al. Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. , 1993, Blood.
[38] G. Hempelmann,et al. Influence of acute preoperative plasmapheresis on platelet function in cardiac surgery. , 1993, Journal of cardiothoracic and vascular anesthesia.
[39] R. Mohr,et al. The hemostatic effect of autologous platelet-rich plasma versus autologous whole blood after cardiac operations: is platelet separation really necessary? , 1993, The Journal of thoracic and cardiovascular surgery.
[40] J. B. Borman,et al. Aprotinin treatment during open heart operation in a patient with severe thrombocytopenia. , 1992, The Annals of thoracic surgery.
[41] J. Amiral,et al. Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia , 1992, Thrombosis and Haemostasis.
[42] A. Greinacher,et al. Heparin‐associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan , 1992, British journal of haematology.
[43] A. Greinacher,et al. Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific , 1992, Thrombosis and Haemostasis.
[44] G. Anderson. Insights into heparin‐induced thrombocytopenia , 1992, British journal of haematology.
[45] J. Gockerman,et al. Parenteral Anticoagulation with the Heparinoid Lomoparan (Org 10172) in Patients with Heparin Induced Thrombocytopenia and Thrombosis , 1992, Thrombosis and Haemostasis.
[46] N. Melling,et al. Platelet-leukocyte plasmapheresis attenuates the deleterious effects of cardiopulmonary bypass. , 1992, The Annals of thoracic surgery.
[47] A. Greinacher,et al. A Rapid and Sensitive Test for Diagnosing Heparin-Associated Thrombocytopenia , 1991, Thrombosis and Haemostasis.
[48] P. T. Larsson,et al. Effects of stress and beta-blockade on platelet function. , 1991, Circulation.
[49] P. Brill-Edwards,et al. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. , 1991, Blood.
[50] L. Kjellén,et al. Heparin or Heparan Sulfate - What is the Difference? , 1991, Thrombosis and Haemostasis.
[51] C. Kessler,et al. Disseminated intravascular coagulation associated with Staphylococcus aureus septicemia is mediated by peptidoglycan-induced platelet aggregation. , 1991, The Journal of infectious diseases.
[52] R. Aster,et al. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. , 1991, Blood.
[53] A. Eldor,et al. Edta‐dependent pseudothrombocytopenia: A clinical study of 18 patients and a review of the literature , 1991, American journal of hematology.
[54] B. Murray,et al. The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis. , 1991, Australian and New Zealand journal of medicine.
[55] P. Eisenberg,et al. Role of new anticoagulants as adjunctive therapy during thrombolysis. , 1991, The American journal of cardiology.
[56] J. George,et al. The clinical importance of acquired abnormalities of platelet function. , 1991, The New England journal of medicine.
[57] P. Damas,et al. Heparin-Induced Thrombocytopenia: A Case Report , 1990, Angiology.
[58] N. Takeyama,et al. Platelet size and function in septic rats: changes in the adenylate pool. , 1990, The Journal of surgical research.
[59] Y. Gruel,et al. Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis , 1990, The Lancet.
[60] S. Karzenski,et al. Warfarin-Induced Skin Necrosis , 1990, Seminars in thrombosis and hemostasis.
[61] D. Silver,et al. Heparin-induced thrombocytopenia in patients who undergo open heart surgery. , 1990, Surgery.
[62] G. Anderson,et al. Signal transduction by the platelet Fc receptor. , 1990, Blood.
[63] T. Ortel,et al. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass. , 1990, Anesthesiology.
[64] K. McCrae,et al. Platelet activation induces increased Fc gamma receptor expression. , 1990, Journal of immunology.
[65] C. Fisher,et al. Intraoperative management of patients with heparin-induced thrombocytopenia. , 1990, The Annals of thoracic surgery.
[66] M. Horne,et al. The effect of molecular weight on heparin binding to platelets , 1990, British journal of haematology.
[67] J. Kelton,et al. Heparin and platelets. , 1990, Hematology/oncology clinics of North America.
[68] S. Keating,et al. Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. , 1989, Anesthesiology.
[69] K. Mulvey,et al. Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin. , 1989, Annals of internal medicine.
[70] R. J. Baird,et al. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis. , 1989, The Annals of thoracic surgery.
[71] B. Chong,et al. Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with platelets , 1989, British journal of haematology.
[72] J. Choay. Structure and Activity of Heparin and Its Fragments: An Overview , 1989, Seminars in thrombosis and hemostasis.
[73] D. Silver,et al. Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies. , 1989, Archives of internal medicine.
[74] J. Bussel. Modulation of Fc receptor clearance and antiplatelet antibodies as a consequence of intravenous immune globulin infusion in patients with immune thrombocytopenic purpura. , 1989, The Journal of allergy and clinical immunology.
[75] B. Chong,et al. Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172 , 1989 .
[76] M. Gimbrone,et al. Interaction of platelet factor four with cultured vascular endothelial cells. , 1989, Blood.
[77] H. Hemker,et al. The Mode of Action of Heparin in Plasma , 1988, Thrombosis and Haemostasis.
[78] N. Starr,et al. Heparin-associated thrombocytopenia: management of patients for open heart surgery. Case reports describing the use of iloprost. , 1988, Anesthesiology.
[79] M. Sobel,et al. Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism. , 1988, Journal of vascular surgery.
[80] J. Kelton,et al. Heparin-induced thrombocytopenia: laboratory studies. , 1988, Blood.
[81] M. Horne. Heparin binding to normal and abnormal platelets. , 1988, Thrombosis research.
[82] M. Sobel,et al. Characterization of platelet binding of heparins and other glycosaminoglycans. , 1988, Thrombosis research.
[83] W. Bell,et al. Heparin-associated thrombocytopenia and thrombosis. , 1988, The Journal of laboratory and clinical medicine.
[84] P. Stanton,et al. White clot syndrome. , 1988, Southern medical journal.
[85] M. Steiner. Platelet surface glycosaminoglycans are an effective shield for distinct platelet receptors. , 1987, Biochimica et biophysica acta.
[86] C. Fisher,et al. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374). , 1987, Surgery.
[87] J. Lowe,et al. Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery. , 1987, The Annals of thoracic surgery.
[88] C. Kessler,et al. In vitro correlation of platelet aggregation with occurrence of disseminated intravascular coagulation and subacute bacterial endocarditis. , 1987, The Journal of laboratory and clinical medicine.
[89] S. Tannenbaum,et al. Immune endothelial-cell injury in heparin-associated thrombocytopenia. , 1987, The New England journal of medicine.
[90] D. Reid,et al. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. , 1987, The Journal of clinical investigation.
[91] P. Castaldi,et al. Heparin‐induced thrombocytopenia: further studies of the effects of heparin‐dependent antibodies on platelets , 1986, British journal of haematology.
[92] J. Vender,et al. Heparin-associated thrombocytopenia: alternative managements. , 1986, Anesthesia and analgesia.
[93] L. Greenfield,et al. Dextran 40 reduces heparin-mediated platelet aggregation. , 1986, The Journal of surgical research.
[94] D. Mikhailidis,et al. Heparin‐induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease , 1985, European journal of clinical investigation.
[95] H. Büller,et al. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs. , 1985, The Journal of laboratory and clinical medicine.
[96] J. Penner,et al. Complications of heparin administration in normal individuals , 1985, American journal of hematology.
[97] Y. Gruel,et al. Treatment of Heparin-Associated Thrombocytopenia and Thrombosis with Low Molecular Weight Heparin (CY 216) , 1985, Seminars in thrombosis and hemostasis.
[98] Long Rw. Management of patients with heparin-induced thrombocytopenia requiring cardiopulmonary bypass. , 1985 .
[99] E. R. Worth,et al. Extracorporeal circulation in a patient with heparin-induced thrombocytopenia. , 1985, Anesthesiology.
[100] G. Olinger,et al. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation. , 1984, The Journal of thoracic and cardiovascular surgery.
[101] D. J. King,et al. Heparin-associated thrombocytopenia. , 1984, Annals of internal medicine.
[102] J. Kelton,et al. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. , 1984, The Journal of laboratory and clinical medicine.
[103] D. Lane,et al. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. , 1984, The Biochemical journal.
[104] M. Petitou,et al. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.
[105] D. Silver,et al. Heparin-induced thrombocytopenia with thrombosis and hemorrhage. , 1983, Archives of surgery.
[106] D. Lane,et al. Binding of platelet factor 4 to heparin oligosaccharides. , 1983, The Biochemical journal.
[107] C. Prowse,et al. The in vivo release of human platelet factor 4 by heparin. , 1982, Thrombosis research.
[108] T. Bjornsson,et al. Heparin kinetics determined by three assay methods , 1982, Clinical pharmacology and therapeutics.
[109] C. S. Grace,et al. Heparin‐induced Thrombocytopenia: Effect of Heparin Platelet Antibody on Platelets , 1981, British journal of haematology.
[110] J. Holbrook,et al. The transfer of platelet factor 4 from its proteoglycan carrier to natural and synthetic polymers. , 1981, Biochimica et biophysica acta.
[111] A. Schreiber,et al. Heparin-associated thrombocytopenia. , 1980, The New England journal of medicine.
[112] D. Pepper,et al. Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. , 1980, Thrombosis research.
[113] D. Deykin,et al. Heparin‐induced thrombocytopenia and recurrent thromboembolism , 1980, American journal of hematology.
[114] V. Bernhard,et al. White clot syndrome. Peripheral vascular complications of heparin therapy. , 1979, Archives of surgery.
[115] D. Stechschulte,et al. Thrombocytopenia associated with antiheparin antibody. , 1978, JAMA.
[116] D. Silver,et al. Heparin Induced Thrombocytopenia: Eight Cases with Thrombotic‐Hemorrhagic Complications , 1977, Annals of surgery.
[117] B. Evatt,et al. In vitro studies of heparin-associated thrombocytopenia. , 1977, Thrombosis research.
[118] P. Tomasulo,et al. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. , 1976, Annals of internal medicine.
[119] R. B. Babcock,et al. Heparin-induced immune thrombocytopenia. , 1976, The New England journal of medicine.
[120] H. Gralnick,et al. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. , 1975, Blood.
[121] D. Silver,et al. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. , 1973, Surgery, gynecology & obstetrics.
[122] E. Lüscher,et al. Characterization of a chondroitin 4 -sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4 ) released from human blood platelets. , 1972, Biochimica et biophysica acta.
[123] B. Roberts,et al. HEPARIN--A CAUSE OF ARTERIAL EMBOLI? , 1964, Surgery.
[124] A. Ulin,et al. Heparin-induced thrombocytopenia in man. , 1962, The Journal of laboratory and clinical medicine.
[125] R. Weismann,et al. Arterial embolism occurring during systemic heparin therapy. , 1958, A.M.A. archives of surgery.
[126] Jaques Lb,et al. The effect of commercial heparin on the platelet count. , 1948, The Journal of laboratory and clinical medicine.
[127] J. Amiral,et al. Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 Cases , 1995, Thrombosis and Haemostasis.
[128] J. Scott,et al. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. , 1994, The Journal of clinical investigation.
[129] B. Chong,et al. Orgaran in Heparin-lnduced Thrombocytopenia , 1992 .
[130] D. Hoppensteadt,et al. Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin. , 1991, Seminars in thrombosis and hemostasis.
[131] J. Hirsh. Drug therapy : heparin , 1991 .
[132] B. Casu,et al. Structural features and binding properties of chondroitin sulfates, dermatan sulfate, and heparan sulfate. , 1991, Seminars in thrombosis and hemostasis.
[133] S. Adnot,et al. Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia. , 1987, Haemostasis.
[134] R. Hull,et al. Antithrombotic therapy for venous thromboembolic disease. , 1986, Chest.
[135] J. Kelton,et al. A diagnostic test for heparin-induced thrombocytopenia , 1986 .
[136] J. George,et al. Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4 , 1982 .
[137] R. Rosenberg,et al. Effect of heparin and heparin fractions on platelet aggregation. , 1980, The Journal of clinical investigation.
[138] L. Jaques,et al. Vascular sequestration of heparin. , 1978, Thrombosis research.